Edoardo Cignoli : Another Acquisition for AstraZeneca

Anglo-Swedish drugs giant AstraZeneca said its MedImmune biological drugs unit would acquire Amplimmune, a privately held company which seeks to harness the human immune system to fight cancer, in a deal worth up to $500 million.



via WSJ.com: US Business http://online.wsj.com/article/SB10001424127887323906804579036570634236950.html?mod=pls_whats_news_us_business_f